Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03320850 Completed - Clinical trials for Urinary Incontinence

BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence

APOLLO
Start date: October 4, 2017
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety of BOTOX® intravesical instillation in participants with overactive bladder and urinary incontinence.

NCT ID: NCT03320694 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus

Start date: February 1, 2016
Phase: Phase 3
Study type: Interventional

Gestational diabetic mellitus (GDM) patients randomised to metformin or insulin group.Aim was to achieve blood sugar levels of Blood sugar fasting (BSF) <5.3 mmol/l and 1 hour post meal<7.8mmol/l. Both groups were followed till delivery and outcome studied.

NCT ID: NCT03320603 Completed - Clinical trials for Emergency Care for Severe Bleeding While on Anticoagulants

Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants

Start date: October 13, 2017
Phase: N/A
Study type: Interventional

The study is assessing the impact of an expert eCRF on the management of severe bleeding in the administration of Prothrombin Complex Concentrate in patients treated with oral anticoagulants and adherence to recommendations or experts' consensus

NCT ID: NCT03320213 Completed - Clinical trials for Threatened Miscarriage in First Trimester

Value of CA125 and Yolk Sac Morphology in Prediction of Pregnancy Outcome in Threatened Miscarriage

Start date: October 1, 2016
Phase: N/A
Study type: Observational

evaluation of serum CA125 level and yolk sac morphology in women with threatened miscarriage is very important to predict pregnancy outcome

NCT ID: NCT03320187 Completed - Clinical trials for Induction of Labor Affected Fetus / Newborn

Nitroglycerin Skin Patches for Facilitating Cervical Ripening: A Randomized Controlled Trial

Start date: December 2016
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to establish the efficacy of transdermal glyceryl trinitrate as a nitric oxide donor in addition to dinoprostone for induction of cervical ripening in the third trimester through progression in the Bishop's score during 24 hour period.

NCT ID: NCT03320135 Completed - Clinical trials for Generalized Aggressive Periodontitis

EMD for Treatment of Proximal Class-II Furcation Involvements

OFD
Start date: October 20, 2017
Phase: N/A
Study type: Interventional

The aim of the present study is to evaluate the clinical response of proximal furcations treated with enamel matrix derivative proteins (EMD).

NCT ID: NCT03320122 Completed - Pediatrics Clinical Trials

School-Based Tele-Physiatry Assistance for Rehabilitative and Therapeutic Services

STARS
Start date: February 1, 2017
Phase: N/A
Study type: Interventional

Using a randomized trial design, the goal of this project is to prospectively compare outcomes from a telemedicine-based model of care to two cohorts: patients who receive in-person pediatric physiatrist medical direction (the "gold standard"), and those who receive medical oversight from non-specialist community providers. This project will determine the impact of this new model of care using telemedicine on parent/guardian satisfaction, adherence rates to an evidence-based hip surveillance program, and economic efficiency.

NCT ID: NCT03320083 Completed - Clinical trials for Sleep Initiation and Maintenance Disorders

Behavioral Insomnia of Childhood: Impact of Parent Education

Start date: February 1, 2016
Phase: N/A
Study type: Interventional

Behavioral Insomnia of Childhood (BIC) is among the most prevalent problem presented to pediatricians with a reported occurrence of approximately 30% worldwide.The most widely applied treatment strategies for BIC in infants comprise behavioral procedures such as unmodified extinction; graduated extinction (ignoring the infant cries with minimal checks), or camping out. Unfortunately, breastfeeding is usually considered as an undesirable sleep association in these strategies. Moreover, less is known regarding the effects of these interventions on breastfeeding outcomes. The cued care is defined as a pattern of care characterized by sensible caregiver responsiveness, which meets the need underlying the infant's cues in a flexible manner. In this context, POSSUMS has been developed as a cued care sleep intervention, which is quite different from the conventional sleep training techniques. In the current study, investigators hypothesized that mothers receiving the cued care sleep intervention would report less sleep problems in their infants. Secondary outcomes included improvement in maternal mood and maintenance of the breastfeeding during the observation period.

NCT ID: NCT03319979 Completed - Clinical trials for Characterize rs70991108 Polymorphism of DHFR Gene

DHFR 19 bp Deletion Polymorphism and Folic Acid Utilization

Start date: February 2013
Phase: N/A
Study type: Observational

A genetic variation in the gene for the protein dihydrofolate reductase (DHFR) that is necessary to utilize folic acid (a synthetic form of the B vitamin folate found in supplements and fortified food), increases the risk for breast cancer in multivitamin users and, when present in mothers who used folic acid supplements during pregnancy, increases the risk for cancer of the eye of their children. The aim of the proposed research is to understand how a common genetic variation in the gene for DHFR affects the function of this protein and the ability of the body to use folic acid.

NCT ID: NCT03319745 Completed - Clinical trials for Stage III Bladder Cancer AJCC v8

Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy

Start date: January 11, 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies the side effects of pembrolizumab and to see how well it works in treating patients with bladder cancer who are undergoing surgery to remove the bladder. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.